期刊
CURRENT OPINION IN IMMUNOLOGY
卷 23, 期 5, 页码 679-684出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2011.06.006
关键词
-
类别
资金
- German Research Foundation (DFG)
- European Commission
- Wilhelm Sander and the Jose Carreras Foundations
- German Ministry of Education and Science (BMBF)
- Bavarian lmmunotherapy Network (BaylmmuNet)
The adoptive transfer of donor-type CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) protects from graft-versus-host disease in murine bone marrow transplantation models. Results from first clinical trials exploring such strategies have recently been presented and seem to confirm the efficacy of Treg for the prevention of this severe complication after allogeneic stem cell transplantation. Further improvements in Treg isolation and in vitro expansion technologies will facilitate the broader exploration of Treg therapies, for example, for the treatment of ongoing graft-versus-host disease or the prevention of graft rejection after solid organ transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据